Marksans Pharma P/B Ratio
Marksans Pharma (MARKSANS) P/B ratio is 4.95 (High), book value per share ₹678.44 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore Marksans Pharma intrinsic price to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MARKSANS P/B Ratio — Valuation Insights & Book Value Analysis
Marksans Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 4.95 (High). For live price, earnings yield and the full fundamental profile, see MARKSANS share price.
- Stock appears overvalued with PB of 4.95, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1107.3% above historical average
- Trading at premium to sector average PB of -0.01
Marksans Pharma P/B Ratio Historical Trend
MARKSANS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read MARKSANS dividend history for the complete payout history and dividend yield track record.
MARKSANS Historical P/B Ratio — Book Value Per Share & Year-End Price
Marksans Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.47 | ₹678.44 | ₹320.15 | ₹3,053 | Low |
| 2025 | 0.33 | ₹553.11 | ₹180.29 | ₹2,489 | Low |
| 2024 | 0.64 | ₹463.56 | ₹296.65 | ₹2,086 | Low |
| 2023 | 0.41 | ₹392.22 | ₹161.10 | ₹1,765 | Low |
| 2022 | 0.2 | ₹298.29 | ₹58.25 | ₹1,223 | Low |
MARKSANS vs Healthcare Peers — P/B Ratio Comparison
Marksans Pharma P/B 4.95 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |